• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国东北地区抗亮氨酸丰富胶质瘤失活 1 脑炎的临床特征。

Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.

机构信息

Department of Neurology, Neuroscience Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, Jilin, China.

Department of Emergency, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, Jilin, China.

出版信息

Clin Neurol Neurosurg. 2021 Apr;203:106542. doi: 10.1016/j.clineuro.2021.106542. Epub 2021 Feb 2.

DOI:10.1016/j.clineuro.2021.106542
PMID:33706063
Abstract

AIM

To examine the clinical characteristics, laboratory tests, imaging and electroencephalography presentation, treatment, and prognosis of anti-leucine-rich glioma-inactivated 1 (anti-LGI1) encephalitis and improve the awareness of this disease.

METHOD

We performed a retrospective analysis of the clinical data of 41 patients who were diagnosed with anti-LGI1 encephalitis. Their clinical characteristics, laboratory tests, and imaging and electroencephalography data were collected, and the treatment results and prognosis were evaluated. The modified Rankin Scale (mRS) was used to evaluate neurological function.

RESULTS

A total of 41 patients were included in the study, the average follow-up time is 33.0 months.The initial symptoms included cognitive impairment (n = 16, 39.0%),faciobrachial dystonic seizures (FBDS) (n = 12, 29.3%), grand mal seizures (n = 5, 12.2%) hallucinations (n = 4, 9.8%), loss of consciousness (n = 2, 4.9%), nausea and vomiting (n = 1, 2.4%),and head discharge-like sensation and radiate one limb (n = 1, 2.4%). There were 20 and 21 patients in the good (mRS ≤ 2) and poor (mRS > 2) prognosis groups, respectively. In the good prognosis group, the initial symptoms included faciobrachial dystonic seizures (FBDS) (n = 6, 30.0%), cognitive impairment (n = 6, 30.0%), hallucinations (n = 4, 20.0%), grand mal seizures (n = 3, 15.0%), loss of consciousness (n = 2, 10.0%), and nausea and vomiting (n = 1, 5.0%). There were 10 patients with hyponatremia. Magnetic resonance imaging (MRI) showed limbic system involvement in 12 patients (60.0%).17 patients (85.0%) recovered, 2 (10.0%) showed significant improvement, and 1 (5.0%) died after a mean follow-up period of 36.9 months. In the poor prognosis group, the initial symptoms included FBDS (n = 6, 28.5%), cognitive impairment (n = 10, 47.6%), grand mal seizures (n = 2, 9.5%), and electric shock-like sensation in the left limbs (n = 1, 4.7%). There were 20 patients with hyponatremia. MRI showed limbic system involvement in 11 patients (52.4%). 11 patients (52.4%) recovered, 8 (38.1%) showed significant improvement, and 2 (9.5%) died after a mean follow-up period of 29.0 months.

CONCLUSIONS

The clinical characteristics of anti-LGI1 encephalitis include hyponatremia, FBDS, epileptic seizures, hallucinations, cognitive impairment, and loss of consciousness, while the rarely seen characteristics are nausea, vomiting, and other autonomic dysfunctions and electric shock-like sensation. The appearance of hallucinations often indicates a good prognosis.Hyponatremia and elevated cerebrospinal fluid protein levels can be used as indicators that affect the prognosis of patients.Limbic system involvement has nothing to do with prognosis.Attention should be paid to early diagnosis and timely first-line immunotherapy.

摘要

目的

探讨抗亮氨酸丰富胶质瘤失活 1 型(anti-LGI1)脑炎的临床特征、实验室检查、影像学和脑电图表现、治疗及预后,提高对本病的认识。

方法

回顾性分析 41 例诊断为抗-LGI1 脑炎患者的临床资料,收集其临床特征、实验室检查及影像学和脑电图资料,评估治疗效果及预后。采用改良 Rankin 量表(mRS)评估神经功能。

结果

共纳入 41 例患者,平均随访时间为 33.0 个月。首发症状包括认知障碍(n=16,39.0%)、面臂肌张力障碍发作(FBDS)(n=12,29.3%)、全面强直阵挛发作(n=5,12.2%)、幻觉(n=4,9.8%)、意识障碍(n=2,4.9%)、恶心呕吐(n=1,2.4%)和头放电样感觉及放射至单肢(n=1,2.4%)。预后良好(mRS≤2)和预后不良(mRS>2)组分别为 20 例和 21 例。在预后良好组中,首发症状包括 FBDS(n=6,30.0%)、认知障碍(n=6,30.0%)、幻觉(n=4,20.0%)、全面强直阵挛发作(n=3,15.0%)、意识障碍(n=2,10.0%)和恶心呕吐(n=1,5.0%)。低钠血症 10 例。磁共振成像(MRI)显示边缘系统受累 12 例(60.0%)。17 例(85.0%)患者痊愈,2 例(10.0%)显著改善,1 例(5.0%)死亡,平均随访 36.9 个月。在预后不良组中,首发症状包括 FBDS(n=6,28.5%)、认知障碍(n=10,47.6%)、全面强直阵挛发作(n=2,9.5%)和左上肢电击样感觉(n=1,4.7%)。低钠血症 20 例。MRI 显示边缘系统受累 11 例(52.4%)。11 例(52.4%)患者痊愈,8 例(38.1%)显著改善,2 例(9.5%)死亡,平均随访 29.0 个月。

结论

抗-LGI1 脑炎的临床特征包括低钠血症、FBDS、癫痫发作、幻觉、认知障碍和意识障碍,而少见的特征是恶心、呕吐等自主神经功能障碍和电击样感觉。幻觉的出现常提示预后良好。低钠血症和脑脊液蛋白升高可作为影响患者预后的指标。边缘系统受累与预后无关。应注意早期诊断和及时一线免疫治疗。

相似文献

1
Clinical features of anti-leucine-rich glioma-inactivated 1 encephalitis in northeast China.中国东北地区抗亮氨酸丰富胶质瘤失活 1 脑炎的临床特征。
Clin Neurol Neurosurg. 2021 Apr;203:106542. doi: 10.1016/j.clineuro.2021.106542. Epub 2021 Feb 2.
2
Clinical features of 28 cases of antileucinerich gliomainactivated protein 1 encephalitis and anticontactinassociated proteinlike 2 encephalitis.抗亮氨酸丰富的胶质瘤失活蛋白 1 脑炎和抗接触蛋白相关蛋白样 2 脑炎 28 例临床特征。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):386-396. doi: 10.11817/j.issn.1672-7347.2023.220548.
3
Clinical features of patients with anti-leucine-rich glioma inactivated-1 protein associated encephalitis: a Chinese case series.抗亮氨酸丰富胶质瘤失活 1 蛋白相关脑炎患者的临床特征:中国病例系列。
Int J Neurosci. 2019 Aug;129(8):754-761. doi: 10.1080/00207454.2019.1567507. Epub 2019 Feb 15.
4
Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.抗富含亮氨酸胶质瘤失活-1脑炎的临床特征、免疫治疗及预后
J Neuropsychiatry Clin Neurosci. 2022 Spring;34(2):141-148. doi: 10.1176/appi.neuropsych.20120303. Epub 2021 Nov 19.
5
Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study.LGI1抗体脑炎的临床特征与短期预后:一项回顾性病例研究
BMC Neurol. 2018 Jul 6;18(1):96. doi: 10.1186/s12883-018-1099-z.
6
Clinical characteristics of Leucine-rich glioma-inactivated protein 1 antibody-mediated autoimmune encephalitis in a 6-year-old girl: case report and literature reviews.6 岁女童富亮氨酸胶质瘤失活蛋白 1 抗体相关自身免疫性脑炎的临床特征:病例报告及文献复习
BMC Neurol. 2023 Jun 30;23(1):253. doi: 10.1186/s12883-023-03299-z.
7
[Ictal electroencephalography (EEG) activity and cerebral blood flow dynamics as potential pathological indicators: a case of anti-leucine-rich glioma-inactivated 1 protein (LGI1) encephalitis].[发作期脑电图(EEG)活动及脑血流动力学作为潜在病理指标:1例抗富含亮氨酸胶质瘤失活1蛋白(LGI1)脑炎]
Rinsho Shinkeigaku. 2020 Nov 27;60(11):778-785. doi: 10.5692/clinicalneurol.cn-001460. Epub 2020 Oct 27.
8
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.脑脊液中的 CHI3L1 是抗亮氨酸丰富胶质瘤失活 1 脑炎的潜在生物标志物。
Front Immunol. 2023 Jan 5;13:1071219. doi: 10.3389/fimmu.2022.1071219. eCollection 2022.
9
Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.面臂型发作性肌张力障碍:免疫疗法对发作控制和预防认知障碍的影响,表型不断扩大。
Brain. 2013 Oct;136(Pt 10):3151-62. doi: 10.1093/brain/awt212. Epub 2013 Sep 6.
10
Seizure semiology in leucine-rich glioma-inactivated protein 1 antibody-associated limbic encephalitis.富含亮氨酸的胶质瘤失活蛋白1抗体相关边缘叶脑炎的癫痫发作症状学
Epilepsy Behav. 2017 Dec;77:90-95. doi: 10.1016/j.yebeh.2017.08.011. Epub 2017 Oct 17.

引用本文的文献

1
Clinical characteristics and prognosis analysis of acute symptomatic seizures secondary to autoimmune encephalitis.自身免疫性脑炎继发急性症状性癫痫的临床特征及预后分析
Front Neurol. 2024 Oct 30;15:1474888. doi: 10.3389/fneur.2024.1474888. eCollection 2024.
2
Case report: Rapid symptom relief in autoimmune encephalitis with efgartigimod: a three-patient case series.病例报告:依氟鸟氨酸治疗自身免疫性脑炎的快速症状缓解:三例病例系列。
Front Immunol. 2024 Oct 3;15:1444288. doi: 10.3389/fimmu.2024.1444288. eCollection 2024.
3
MR Imaging Findings in Anti-Leucine-Rich Glioma Inactivated Protein 1 Encephalitis: A Systematic Review and Meta-analysis.
抗亮氨酸丰富胶质瘤失活蛋白 1 脑炎的磁共振成像表现:系统评价和荟萃分析。
AJNR Am J Neuroradiol. 2024 Jul 8;45(7):977-986. doi: 10.3174/ajnr.A8256.
4
Origin and significance of leucine-rich glioma-inactivated 1 antibodies in cerebrospinal fluid.脑脊液中富含亮氨酸的胶质瘤失活蛋白 1 抗体的来源和意义。
Neurol Sci. 2024 Sep;45(9):4493-4500. doi: 10.1007/s10072-024-07489-6. Epub 2024 Mar 29.
5
Enhancing the clinical diagnosis of the acute and subacute phases of autoimmune encephalitis and predicting the risk factors: the potential advantages of 18F-FDG PET/CT.增强自身免疫性脑炎急、亚急性期的临床诊断并预测其危险因素:18F-FDG PET/CT 的潜在优势。
BMC Med Imaging. 2023 Nov 20;23(1):193. doi: 10.1186/s12880-023-01148-6.
6
Efficacy of immunotherapy and prognosis in anti-LGI1 encephalitis patients: A meta-analysis.抗 LGI1 脑炎患者免疫治疗的疗效和预后:荟萃分析。
Ann Clin Transl Neurol. 2023 Sep;10(9):1578-1589. doi: 10.1002/acn3.51847. Epub 2023 Jul 13.
7
CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis.脑脊液中的 CHI3L1 是抗亮氨酸丰富胶质瘤失活 1 脑炎的潜在生物标志物。
Front Immunol. 2023 Jan 5;13:1071219. doi: 10.3389/fimmu.2022.1071219. eCollection 2022.
8
Clinical characteristics, long-term functional outcomes and relapse of anti-LGI1/Caspr2 encephalitis: a prospective cohort study in Western China.抗LGI1/Caspr2脑炎的临床特征、长期功能结局及复发:中国西部的一项前瞻性队列研究
Ther Adv Neurol Disord. 2022 Jan 19;15:17562864211073203. doi: 10.1177/17562864211073203. eCollection 2022.
9
The LGI1 protein: molecular structure, physiological functions and disruption-related seizures.LGI1 蛋白:分子结构、生理功能和与紊乱相关的癫痫发作。
Cell Mol Life Sci. 2021 Dec 30;79(1):16. doi: 10.1007/s00018-021-04088-y.